A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution

Biochemical and Biophysical Research Communications

Volumn 310, Issue 3, 2003, Pages 754-760

  Lin, Shi Lung ^a,b   Chang, Donald ^a   Wu, Da Yu ^a   Ying, Shao Yao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Beckman Institute for Biomedical Research   (United States)

Author keywords

Artificial intron; Genetic adaptation; Genome evolution; MiRNA; Pol II based RNA interference; Posttranscriptional gene silencing; Pre mRNA splicing

Indexed keywords

PALINDROMIC DNA; RNA;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DNA PACKAGING; EXON; GENE INSERTION; GENE SILENCING; GENETIC TRANSCRIPTION; GENOME; INTRON; MAMMAL; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; REGULATORY MECHANISM; RNA SPLICING; SPLICEOSOME; TRANSGENE;

MAMMALIA;

EID: 0141534299     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.070     Document Type: Article

References (27)

1. Sittler A., Gallinaro H., Kister L., Jacob M. In-vivo degradation pathway of an excised intervening sequence. J. Mol. Biol. 197:1987;737-741.
2. Clement J.Q., Qian L., Kaplinsky N., Wilkinson M.F. The stability and fate of a spliced intron from vertebrate cells. RNA. 5:1999;206-220.
3. Buchman A.R., Berg P. Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8:1988;4395-4405.
4. Herbert A., Rich A. RNA processing and the evolution of eukaryotes. Nat. Genet. 21:1999;265-269.
5. Modrek B., Lee C.J. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat. Genet. 34:2003;177-180.
6. Lewis B.P., Green R.E., Brenner S.T. Evidence for the widespread coupling of alternative splicing and non-sense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA. 100:2002;189-192.
7. Lynch M., Kewalramani A. Messenger RNA surveillance and the evolutionary proliferation of introns. Mol. Biol. Evol. 20:2003;563-571.
8. Maquat L.E. Defects in RNA splicing and the consequence of shortened translational reading frames. Am. J. Hum. Genet. 59:1996;279-286.
9. Nott A., Meislin S.H., Moore M.J. A quantitative analysis of intron effects on mammalian gene expression. RNA. 9:2003;607-617.
10. Wakutani Y., Kowa H., Kusumi M., Yamagata K., Wada-Isoe K., Adachi Y., Takeshima T., Urakami K., Nakashima K. Genetic analysis of vascular factors in Alzheimer's disease. Ann. NY Acad. Sci. 977:2002;232-238.
11. Lotrich E.F., Pollock B.G., Ferrell R.E. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors. Am. J. Pharmacogenom. 1:2001;153-164.
12. Suspitsin E.N., Buslov K.G., Grigoriev M.Y., Ishutkina J.G., Ulibina J.M., Gorodinskaya V.M., Pozharisski K.M., Berstein L.M., Hanson K.P., Togo A.V., Imyanitov E.N. Evidence against involvement of p53 polymorphism in breast cancer predisposition. Int. J. Cancer. 103:2003;431-433.
13. Sun Y., Keshava C., Sharp D.S., Weston A., McCanlies E.C. DNA sequence variants of p53: cancer and aging. Am. J. Hum. Genet. 65:1999;1779-1782.
14. Rose A.B. Requirements for intron-mediated enhancement of gene expression in Arabidopsis. RNA. 8:2002;1444-1453.
15. Stoutjesdijk P.A., Singh S.P., Liu Q., Hurlstone C.J., Waterhouse P.A., Green A.G. hpRNA-mediated targeting of the Arabidopsis FAD2 gene gives highly efficient and stable silencing. Plant Physiol. 129:2002;1723-1731.
16. Guo H.S., Fei J.F., Xie Q., Chua N.H. A chemical-regulated inducible RNAi system in plants. Plant J. 34:2003;383-392.
17. Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:1996;367-409.
18. Mougin A., Gottschalk A., Fabrizio P., Luhrmann R., Branlant C. Direct probing of RNA structure and RNA-protein interactions in purified HeLa cell's and yeast spliceosomal U4/U6.U5 Tri-snRNP particles. J. Mol. Biol. 317:2002;631-649.
19. Fairbrother W.G., Yeh R.F., Sharp P.A., Burge C.B. Predictive identification of exonic splicing enhancers in human genes. Science. 297:2002;1007-1013.
20. Palmer T.D., Markakis E.A., Willhoite A.R., Safar F., Gage F.H. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci. 19:1999;8487-8497.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
22. Sambrook J., Russell D.W. Molecular Cloning. third ed. 2001;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
23. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science. 297:2002;2056-2060.
24. Zhang G., Taneja K.L., Singer R.H., Green M.R. Localization of pre-mRNA splicing in mammalian nuclei. Nature. 372:1994;809-812.
25. Ghosh S., Garcia-Blanco M.A. Coupled in vitro synthesis and splicing of RNA polymerase II transcripts. RNA. 6:2000;1325-1334.
26. Lin S.L., Chuong C.M., Ying S.Y. A novel mRNA-cDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells. Biochem. Biophys. Res. Commun. 281:2001;639-644.
27. Lin S.L., Ying S.Y. D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. Curr. Cancer Drug Targets. 1:2001;241-247.